3881 - 3890 of 8137 Results
Title
Year
- From trials to clinical practice: Temporal trends in the coverage of specialized allied health services for Parkinson's disease2020OPENTitle: From trials to clinical practice: Temporal trends in the coverage of specialized allied health services for Parkinson's diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: 3Start Page: 775End Page: 782Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ene.14627Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14627Citation Count: 10
- Automated Categorization of Parkinsonian Syndromes Using Magnetic Resonance Imaging in a Clinical Setting2020OPENTitle: Automated Categorization of Parkinsonian Syndromes Using Magnetic Resonance Imaging in a Clinical SettingJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 2Start Page: 460End Page: 470Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28348Best OA location URL: https://hal.sorbonne-universite.fr/hal-03046578v1/file/Chougar%20et%20al.%20-%20Automated%20Categorization%20of%20Parkinsonian%20Syndromes.pdfCitation Count: 36
-
OPENTitle: Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 642End Page: 650Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28360Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/167040/1/mds28360_am.pdfCitation Count: 63
- Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?2020OPENTitle: Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?Journal Name: Neurological Research and PracticePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s42466-020-00076-yBest OA location URL: https://neurolrespract.biomedcentral.com/track/pdf/10.1186/s42466-020-00076-yCitation Count: 2
-
OPENTitle: Endogenous Rab29 does not impact basal or stimulated LRRK2 pathway activityJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 477Issue #: 22Start Page: 4397End Page: 4423Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20200458Best OA location URL: https://portlandpress.com/biochemj/article-pdf/477/22/4397/898287/bcj-2020-0458.pdfCitation Count: 67
- Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson’s Disease: Expert Review and Commentary2020OPENTitle: Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson’s Disease: Expert Review and CommentaryJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 7End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-020-00220-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-020-00220-5.pdfCitation Count: 41
-
OPENTitle: Lack of evidence for association of UQCRC1 with Parkinson's disease in EuropeansJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 101Issue #:Start Page: 297.e1End Page: 297.e4Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.10.030Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938960Citation Count: 8
- Selective blockade of the 5-HT3 receptor acutely alleviates dyskinesia and psychosis in the parkinsonian marmoset2020RESTRICTEDTitle: Selective blockade of the 5-HT3 receptor acutely alleviates dyskinesia and psychosis in the parkinsonian marmosetJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 182Issue #:Start Page: 108386End Page: 108386Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2020.108386Citation Count: 14
-
RESTRICTEDTitle: The Emerging Role of the Lysosome in Parkinson’s DiseaseJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 11Start Page: 2399End Page: 2399Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9112399Best OA location URL: https://www.mdpi.com/2073-4409/9/11/2399/pdf?version=1604479812Citation Count: 74
- Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias2020RESTRICTEDTitle: Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementiasJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 951End Page: 962Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/s1474-4422(20)30314-8Best OA location URL: http://manuscript.elsevier.com/S1474442220303148/pdf/S1474442220303148.pdfCitation Count: 283